Key Differences and UK Availability Explained
Understanding the Core Difference Between Wegovy and Mounjaro UK Availability
The primary difference between Wegovy and Mounjaro UK availability lies in their supply chain stability and storage advantages. Wegovy, manufactured by Novo Nordisk, now maintains consistent UK stock levels across all five doses through our GPhC-registered pharmacy (#9012878). After previous supply challenges, the reliable availability of Wegovy represents a significant improvement for patients seeking consistent weight management support. Mounjaro, whilst also available, operates on a different distribution model that can occasionally affect stock levels.
Beyond availability, the fundamental difference between Wegovy and Mounjaro UK patients should understand relates to their mechanisms of action. Wegovy contains semaglutide, a selective GLP-1 receptor agonist that mimics natural fullness hormones. Mounjaro contains tirzepatide, which targets both GIP and GLP-1 receptors simultaneously. This dual-action approach represents a different therapeutic strategy, though both prescription-only medicines require the same clinical assessment and prescriber approval process.
Pricing Comparison: Wegovy vs Mounjaro UK Costs
When comparing the difference between Wegovy and Mounjaro UK pricing, Wegovy offers transparent, competitive rates starting at £79.99 for the 0.25mg starter dose with code FIRST40 at checkout. The complete dose escalation journey spans five doses: 0.25mg (£79.99), 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), and maintenance 2.4mg (£209.99). Our Getting Started bundles provide convenient progression packs, such as the Intro Duo (0.25mg & 0.5mg) for £169.99. Returning customers benefit from code DOSE25 for ongoing maintenance supplies.
The key difference between Wegovy and Mounjaro UK pricing structures also involves bundle availability and long-term cost planning. Wegovy's established dose escalation protocol allows for predictable budgeting across the 16-week titration period. Our Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99, ensuring uninterrupted treatment. This transparent pricing structure helps patients plan their weight management journey without unexpected cost fluctuations that can occur with less established supply chains.
Clinical Evidence: How Wegovy and Mounjaro Compare in UK Trials
The clinical difference between Wegovy and Mounjaro UK patients should understand comes from separate trial programmes with different endpoints and populations. In the STEP trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events with semaglutide treatment.
Mounjaro's SURMOUNT trials showed different results using tirzepatide's dual-receptor approach, though direct comparison isn't appropriate due to varying trial designs and patient populations. Both prescription-only medicines require combination with reduced-calorie diet and increased physical activity. The difference between Wegovy and Mounjaro UK prescribing decisions should always involve clinical assessment of individual patient factors rather than trial-to-trial comparisons.
How Wegovy Works: GLP-1 Mechanism Explained
Understanding how Wegovy works helps clarify the difference between Wegovy and Mounjaro UK mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the action of naturally occurring incretin hormones. When injected once weekly using the FlexTouch pen, semaglutide binds to GLP-1 receptors in the brain's appetite control centres, promoting feelings of fullness and reducing food cravings. This mechanism may help patients feel satisfied with smaller portions and experience fewer between-meal hunger sensations. The treatment works by slowing gastric emptying, which extends the feeling of satiety after eating, whilst also influencing neural pathways that regulate appetite and food reward behaviours.
Simple Ordering Process for Both Treatments
The ordering process remains identical whether you choose Wegovy or Mounjaro, eliminating any difference between Wegovy and Mounjaro UK accessibility. Complete our 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our UK-qualified prescribers review applications within three working days (or 24 hours with express service). Once approved, your prescription-only medicine ships via next-day delivery using temperature-controlled cold-chain logistics. All orders are dispatched from our GPhC-registered pharmacy (#9012878) with full MHRA compliance. Track your delivery through our secure patient portal and receive dosing guidance from our clinical team.
Storage and Practical Considerations
A significant practical difference between Wegovy and Mounjaro UK patients often overlook involves storage flexibility and travel convenience. Wegovy maintains potency for up to 6 weeks at room temperature (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day limit. This storage advantage makes Wegovy particularly suitable for frequent travellers or those with limited refrigeration access. Both treatments require initial storage at 2-8°C and use similar pen injection devices. The weekly dosing schedule remains consistent for both options, though Wegovy's established dose escalation protocol (0.25mg to 2.4mg over 16 weeks) provides clear progression milestones. Understanding these practical differences helps patients choose the treatment that best fits their lifestyle and travel requirements.
Supply Chain Reliability: Why Stock Availability Matters
The most crucial difference between Wegovy and Mounjaro UK patients should consider involves supply chain consistency and treatment continuity. Wegovy's improved UK distribution through Novo Nordisk now ensures reliable stock levels across all doses, eliminating the treatment interruptions that previously affected patient outcomes. Missing doses or switching between treatments can impact efficacy and potentially cause side effect recurrence during re-titration. Our established Wegovy supply relationship confirmed stock availability for ongoing patients, with automated refill reminders preventing treatment gaps.
This supply reliability becomes particularly important during maintenance therapy, when consistent dosing supports long-term weight management goals. The difference between Wegovy and Mounjaro UK supply security also affects prescription planning and clinical decision-making. Healthcare providers can confidently initiate Wegovy treatment knowing that dose escalation and maintenance supplies remain available. This supply confidence translates to better patient outcomes through uninterrupted treatment progression and reduced anxiety about medication availability.
Making Your Choice: Expert Guidance Available
Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which option aligns with your individual health profile and lifestyle needs. The difference between Wegovy and Mounjaro UK prescribing decisions should consider factors including medical history, current medications, travel requirements, and personal preferences regarding injection frequency and storage. Our clinical team provides ongoing support throughout your weight management journey, regardless of which treatment you choose. Start your assessment today using code FIRST40 for new customers or DOSE25 for returning patients, with next-day delivery available following prescriber approval. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment and access both treatment options through our secure, regulated platform.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
